Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years (Q40891715)

24 September 2017

title

Declining Effectiveness of Herpes Zoster Vaccine in Adults Aged ≥60 Years (English)

1 reference

24 September 2017

1 reference

9

Steven J Jacobsen

1 reference

24 September 2017

6

Sara Y Tartof

1 reference

24 September 2017

7

Stephanie Bialek

1 reference

24 September 2017

Hung Fu Tseng

1

1 reference

24 September 2017

Rafael Harpaz

2

1 reference

24 September 2017

Yi Luo

3

1 reference

24 September 2017

Craig M Hales

4

1 reference

24 September 2017

Lina S Sy

5

1 reference

24 September 2017

Rulin C Hechter

8

1 reference

24 September 2017

language of work or name

English

0 references

publication date

9 February 2016

1 reference

Journal of Infectious Diseases

24 September 2017

published in

1 reference

24 September 2017

volume

213

1 reference

24 September 2017

issue

12

1 reference

24 September 2017

page(s)

1872-1875

1 reference

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Long-term persistence of zoster vaccine efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Race and ethnicity data quality and imputation using U.S. Census data in an integrated health system: the Kaiser Permanente Southern California experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Herpes zoster vaccine in older adults and the risk of subsequent herpes zoster disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

A Population-Based Study of the Incidence and Complication Rates of Herpes Zoster Before Zoster Vaccine Introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Incidence of herpes zoster, 1997-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Incidence of Herpes Zoster, Before and After Varicella‐Vaccination–Associated Decreases in the Incidence of Varicella, 1992–2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIW047

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIW047

1 reference

24 September 2017

1 reference